FDA Clears Cingulate to File for Marketing Approval of
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners...
Source: globenewswire.com
Behavior Medicine News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Behavior Medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Behavior Medicine Today - Breaking & Trending Today
FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD Patients Currently ...
Source: businessinsider.com
Top 10 Most Aggressive Dog Breeds
The most aggressive dog breeds may surprise you. Toy breeds like miniature poodles and Chinese crested dogs make the list.
Source: newsweek.com
Cingulate to Host CNS Key Opinion Leader Panel in New York
Expert Analysis of Cingulate, its Phase 3 ADHD Adult Data, Anxiety, and PTR™ Drug Delivery Platform Innovations...
Source: globenewswire.com
Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its...
Source: marketscreener.com